An Evaluation of Key Biological Treatments for Mental Health Disorders
Homework type: Essay
Added: an hour ago
Summary:
Explore key biological treatments for mental health disorders, their effectiveness, and ethical considerations to enhance your understanding of UK clinical approaches.
Treatments of the Biological Approach and Their Evaluation
The biological approach in psychology is rooted in the belief that mental health problems are fundamentally biological in origin. This perspective frames psychological disorders as arising from physiological or neurochemical disturbances within the brain, such as imbalances in neurotransmitters or structural anomalies. In the landscape of modern mental health care, particularly within British society and the NHS system, this approach has given rise to an array of medical interventions designed to target the biological substrates of mental illness.
The intention of this essay is twofold: first, to explain some of the principal biological treatments available for psychological disorders, with an emphasis on pharmacological therapies; and second, to critically evaluate these treatments with reference to their effectiveness, drawbacks, and ethical considerations. Throughout, I will draw upon examples from British clinical practice, cite classic and contemporary research findings, and highlight cultural considerations unique to the UK setting.
The essay will begin by outlining the main forms of biological intervention, then describe the neurobiological mechanisms that underpin their use. Subsequent sections will examine the most prominent classes of medication—antidepressants, anxiolytics, and antipsychotics—before moving to a critique encompassing efficacy, limitations, and societal implications. Finally, I will reflect on recent advances in the field and propose directions for future practice.
---
Biological Treatments Overview
Fundamentally, the biological approach contends that psychiatric conditions stem from underlying dysfunctions in the brain's chemistry or structure. The guiding aim is to adjust these dysfunctions—whether a depleted neurotransmitter or an overactive neural circuit—through targeted intervention. This conceptualisation has immense real-world consequences: it legitimises mental illness as analogous to a physical health condition and underpins the widespread medicalisation of psychological distress.The main forms of biological treatment reflect this medical model. Pharmacotherapy—or the use of drugs to treat mental health disorders—remains the dominant method. The most familiar are:
- Antidepressants: Used to manage major depressive disorder, some anxiety disorders, and obsessive-compulsive disorder. - Anxiolytics: Prescribed to alleviate pathological anxiety and agitation. - Antipsychotics: Employed above all in the management of psychotic conditions like schizophrenia.
Other approaches of note include electroconvulsive therapy (ECT)—largely reserved for severe, treatment-resistant depression in the UK—and emerging interventions such as deep brain stimulation (DBS) and repetitive transcranial magnetic stimulation (rTMS). However, for brevity and focus, this essay will concentrate on drug treatments as they represent the biological paradigm's centrepiece within British clinical practice.
---
Neurobiological Underpinnings of Treatments
Central to the biological approach is an understanding of neurotransmitters, the chemical messengers of the brain. Disrupted neurotransmission is believed to underlie many mental health problems, and the manipulation of these pathways forms the chief rationale for biological treatment.- Dopamine: Essential to the brain’s reward, pleasure, and motivational systems. Excess dopamine has been implicated in psychosis—most notably, the positive symptoms of schizophrenia, such as hallucinations and delusions. - Serotonin: Widely regarded as the mood stabiliser of the brain. Low serotonin levels are associated with depression and several anxiety conditions. - GABA (gamma-aminobutyric acid): The major inhibitory neurotransmitter, responsible for dampening nerve activity. A deficiency or skewed GABA signalling is linked to heightened anxiety. - Noradrenaline: Involved in the body’s arousal system and stress response; imbalances may contribute to mood and anxiety disorders.
Medications harness these neurobiological connections. Antidepressants typically work either by increasing serotonin (e.g., SSRIs like sertraline and citalopram, both common on NHS prescriptions) or noradrenaline in the brain. Anxiolytics such as benzodiazepines potentiate GABA’s calming effects, reducing the overstimulation characteristic of anxiety states. Antipsychotics predominantly block dopamine receptors, thus dampening the aberrant neural signalling associated with psychosis.
The biological justification for such interventions is compelling: if a disrupted neurochemical environment causes a mental health issue, then pharmacological rebalancing should, in theory, restore psychological well-being.
---
Detailed Examination of Biological Treatments
Antidepressants
Antidepressant medication is one of the most commonly prescribed treatments within British mental health care. First developed in the 1950s, the field now encompasses several major types:- SSRIs (Selective Serotonin Reuptake Inhibitors): These, including fluoxetine (Prozac), sertraline, and paroxetine, work by preventing serotonin reabsorption in the brain, thereby increasing its levels. - Tricyclic Antidepressants (TCAs): Older drugs, such as amitriptyline, function by inhibiting the reuptake of both noradrenaline and serotonin. They are less favoured today due to their side effect profile and risk in overdose. - Monoamine Oxidase Inhibitors (MAOIs): Now rarely used, these block the enzyme responsible for breaking down key neurotransmitters. They require strict dietary management due to potentially dangerous interactions.
Antidepressants are most often used for major depressive disorder and to some extent for anxiety-based conditions including generalised anxiety disorder and obsessive-compulsive disorder. They typically require several weeks to manifest meaningful therapeutic effects, a detail that can cause patient frustration. A large-scale review in The Lancet (Cipriani et al., 2018) found that, overall, antidepressants are more effective than placebo, though individual response varies considerably.
Anxiolytics
The most familiar anxiolytics are benzodiazepines (for example, diazepam—known popularly as Valium). These drugs interact with GABA receptors, enhancing the neurotransmitter’s natural sedative influence and mitigating excessive nervous activity.Benzodiazepines are used for short-term relief of severe anxiety, including panic attacks, and as muscle relaxants. They are not viewed as a long-term option due to the risk of dependency and tolerance, as documented by both NICE guidelines and widespread clinical caution in the UK.
Antipsychotics
Antipsychotic drugs are divided into two broad categories:- Typical (first-generation) antipsychotics: These include chlorpromazine and haloperidol. They are effective at treating the positive symptoms of schizophrenia but often cause severe side effects, such as tremors, muscle stiffness, and tardive dyskinesia (involuntary movements). - Atypical (second-generation) antipsychotics: Such as risperidone and olanzapine, these are designed to reduce side effects and also address negative symptoms (flattened affect, social withdrawal). They act on both dopamine and serotonin systems.
Antipsychotic medications frequently have a sedative effect and are used in the management of bipolar disorder and severe depression in addition to schizophrenia. Long-term use mandates vigilance for metabolic side effects, such as significant weight gain and increased diabetes risk.
---
Critical Evaluation of Biological Treatments
Effectiveness and Efficacy
There is robust evidence that biological treatments alleviate symptoms for many mental health disorders. For example, data from NHS Digital reveals a steady year-on-year increase in antidepressant prescriptions, indicating both the prevalence of such conditions in society and the perceived benefit of these drugs. However, the efficacy varies markedly; not all patients benefit equally, and some experience little improvement.A significant criticism is that these treatments primarily address symptoms rather than root causes. While drugs can lift mood or stifle hallucinations, they do little to tackle contributing factors such as trauma, social isolation, or maladaptive thought patterns. Furthermore, the placebo effect in mental health trials is notoriously high, complicating assessments of real therapeutic value.
Side Effects and Risks
The side effect profiles of biological treatments can be substantial. Antidepressants may provoke nausea, sexual dysfunction, drowsiness, or weight gain. Antipsychotics—particularly first-generation types—carry severe risks like tardive dyskinesia and metabolic syndrome. Anxiolytics, promising instantaneous relief, often foster dependence, meaning patients may struggle to cease their medication without withdrawal symptoms.Such adverse effects are particularly concerning given that they can undermine a patient's quality of life and diminish adherence to treatment regimens, often leading to a revolving door cycle in care.
Limitations and Critiques
A fundamental problem lies in the reductionism of the biological approach. By prioritising drugs, there is a risk of neglecting psychological, cultural, and social influences. The Royal College of Psychiatrists has repeatedly emphasised the importance of integrated, person-centred care that values talking therapies alongside medication. Critics, such as clinical psychologist David Pilgrim, have argued that over-medicalisation perpetuates stigma and reduces agency in service users.Biological treatments also struggle with chronicity. Many drugs must be taken indefinitely to prevent symptom relapse, arguably positioning service users as dependent rather than recovered.
Ethical Issues
Questions of informed consent and patient autonomy are central in discussions of biological treatment. Is it ethical to prescribe medications with considerable side effects, sometimes to individuals who are unwell enough to struggle with decision-making? British mental health legislation, notably the Mental Health Act, enshrines patient rights, but cases of coercion, especially with antipsychotic use, still surface.Moreover, societal attitudes in the UK towards psychiatric drugs remain ambivalent—while the NHS strives to reduce stigma, media narratives and personal testimonies often highlight fears of over-prescription and pharmaceutical overreach.
Combined Treatments
Most psychiatric guidelines now recommend that medication be paired with psychological interventions such as cognitive behavioural therapy (CBT). Empirical research has demonstrated that combined treatment yields better long-term outcomes, strongly supporting a holistic approach. The Improving Access to Psychological Therapies (IAPT) initiative reflects the NHS’s ongoing commitment to such integrative care.---
Broader Implications and Future Directions
Pharmacological advances are leading towards drugs with more targeted action and fewer undesirable effects. Genetic and neuroimaging research promises a future of ‘precision psychiatry’, where treatment is tailored to an individual's biological profile. Neuromodulation therapies, like rTMS, are gaining a foothold, offering non-drug alternatives for resistant conditions.However, these innovations raise new ethical dilemmas, from questions of cost and access, to the role of biotechnology in defining normality. Continual research, clinical trials, and public debate will be crucial as the field evolves.
---
Conclusion
Biological treatments have transformed the landscape of mental health through their ability to alleviate symptoms by correcting neurochemical imbalances. Their overall effectiveness is beyond question, but their impact is uneven and often accompanied by considerable adverse effects and ethical concerns.It is increasingly recognised within British mental health services that medication alone is rarely sufficient, and that truly effective care requires an integrated approach respecting both biological and psychosocial realities. Advances in pharmacology and neuroscience hold much promise, but must be pursued with humanity and vigilance.
In sum, the biological approach remains vital to the field of psychological treatment, but its limitations compel us to treat individuals, not just diagnoses—appreciating the complexity and individuality of every person behind the prescription.
Rate:
Log in to rate the work.
Log in